Cancer BiologybioRxivPreprint
Novel allosteric mechanism of p53 activation by small molecules for targeted anticancer therapy
Joanna Zawacka-Pankau, Vera V. Grinkevich, Mikhail Burmakin…·Galina Selivanova
This study identifies a novel allosteric mechanism by which small molecules activate p53 by blocking MDM2/MDMX binding, offering a new approach for anticancer therapy.
DOI 10.1101/384248